CytomX Therapeutics to Participate at Upcoming Healthcare Conferences

NEXT STORY
Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders
PREV STORY
Adverum Biotechnologies Announces New INFINITY Phase 2 Trial for ADVM-022 in Diabetic Macular Edema, Reports Recent Business Progress and First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pivotal Phase III data at ASCO show Roche’s Tecentriq helps certain people with early lung cancer live significantly longer without their disease returning

author_avatar
NASDAQ Market News

American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa

author_avatar
NASDAQ Market News

Relay Announces Engagement with Canadian MedTech Leader, StarFish Medical, to provide Cybeats Integrated Security Platform for Connected Medical Devices

author_avatar
NASDAQ Market News